相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impact of ABO and Rhesus blood groups on COVID-19 susceptibility and severity: A case-control study
Anthony Kerbage et al.
JOURNAL OF MEDICAL VIROLOGY (2022)
Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review
Kazuhiro Ishikawa et al.
AMERICAN JOURNAL OF CASE REPORTS (2022)
Stenotrophomonas maltophilia Bacteremia Associated With Severe COVID-19: Successful Treatment With Appropriate Antimicrobial Therapy
Masaatsu Kuwahara et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2022)
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Richard G. Wunderink et al.
LANCET INFECTIOUS DISEASES (2021)
Comparative evaluation of ventilator-associated pneumonia in critically ill COVID- 19 and patients infected with other corona viruses: a systematic review and meta-analysis
Shikha Jain et al.
Monaldi Archives for Chest Disease (2021)
Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia
Chiagozie O. Pickens et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Ventilator-Associated Pneumonia in COVID-19 Patients: A Retrospective Cohort Study
Maxence Rouyer et al.
ANTIBIOTICS-BASEL (2021)
Ventilator-associated pneumonia in critically ill patients with COVID-19
Mailis Maes et al.
CRITICAL CARE (2021)
Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients
C. H. Wang et al.
JOURNAL OF HOSPITAL INFECTION (2020)
Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole
M. Biagi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome
Wafa Ibn Saied et al.
JOURNAL OF INFECTION (2020)
Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia
Waki Imoto et al.
INTERNAL MEDICINE (2020)
Molecular Epidemiology, Antibiotic Resistance, and Virulence Traits of Stenotrophomonas maltophilia Strains Associated With an Outbreak in a Mexican Tertiary Care Hospital
Ariadnna Cruz-Cordova et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
Frederikus A. Klok et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis
Lan Yang et al.
PLOS ONE (2020)
Cluster of S. maltophilia among patients with respiratory tract infections at an intensive care unit
Maria Gideskog et al.
INFECTION PREVENTION IN PRACTICE (2020)
Pneumothorax in COVID-19 disease- incidence and clinical characteristics
Massa Zantah et al.
RESPIRATORY RESEARCH (2020)
The National Early Warning Score 2 (NEWS2)
Gary B. Smith et al.
CLINICAL MEDICINE (2019)
Stenotrophomonas maltophilia biofilm: its role in infectious diseases
Samantha Flores-Trevino et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)
Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
Philippe Guerci et al.
CRITICAL CARE (2019)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
Antoni Torres et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
Pseudo-outbreaks of Stenotrophomonas maltophilia on an intensive care unit in England
T. D. Waite et al.
JOURNAL OF HOSPITAL INFECTION (2016)
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
Ya-Ting Chang et al.
FRONTIERS IN MICROBIOLOGY (2015)
Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases
Minako Mori et al.
ANNALS OF HEMATOLOGY (2014)
Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage
K. Tada et al.
BONE MARROW TRANSPLANTATION (2013)
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
Joanna S. Brooke
CLINICAL MICROBIOLOGY REVIEWS (2012)
Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients
B. Saugel et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Risk Factors for Mortality in Patients with Nosocomial Stenotrophomonas maltophilia Pneumonia
Chia-Cheng Tseng et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Stenotrophomonas maltophilia: an emerging opportunist human pathogen
W. John Looney et al.
LANCET INFECTIOUS DISEASES (2009)
Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome
Saad Nseir et al.
CRITICAL CARE (2006)
Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea
A Apisarnthanarak et al.
CLINICAL INFECTIOUS DISEASES (2003)
Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients
SD Hanes et al.
CLINICAL INFECTIOUS DISEASES (2002)
Factors affecting the incidence Stenotrophomonas maltophilia isolation in cystic fibrosis
GR Graff et al.
CHEST (2002)